Apogee Therapeutics, Inc.APGENASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-216.68M
↓ 96% below average
Average (2y)
$-110.48M
Historical baseline
Range
High:$-39.78M
Low:$-216.68M
CAGR
+133.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-216.68M | -189.0% |
| 2023 | $-74.97M | -88.4% |
| 2022 | $-39.78M | - |